1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|25|4306-4323

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.25, 2012-09, pp. : 4306-4323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story so Far And Perspectives (Part 1): Action in Ion Channels and GPCRs

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4901-4922

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives in Medicinal Chemistry: DNA Methylation and Demethylation Mechanisms as Therapeutic Targets?

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 8, 2016-03 ,pp. : 807-808

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives in Medicinal Chemistry: Metallomics and New Targets in Metal-Based Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3381-3382

Bentham Science Publishers

Access to resources Recommend Favorite

The NHS: the story so far (1948-2010)

By Shapiro Jonathan  

Clinical Medicine, Vol. 10, Iss. 4, 2010-08 ,pp. : 336-338

Royal College Of Physicians

Access to resources Recommend Favorite

Targeting: The ADEPT Story So Far

By  

Current Drug Targets, Vol. 10, Iss. 2, 2009-02 ,pp. : 152-157

Bentham Science Publishers

Access to resources Recommend Favorite